| Document |
Document Title |
|
WO/2022/180587A1 |
A probiotic for preparing a composition for improving oral immunoglobulin A content and inhibiting oral pathogens and a use, wherein the probiotic comprises Lactobacillus plantarum LPL28 as an active ingredient, and can effectively impro...
|
|
WO/2022/180034A1 |
The invention relates to a method of obtaining a composition comprising allolactose by a applying one or more glucose-deficient lactic acid bacteria strains. The invention also relates to the use of said strains for the preparation of a ...
|
|
WO/2022/178601A1 |
The present invention relates to a composition based on coconut water and cow's milk which are subjected to an appropriate dehydration process. The bioproduct has been developed so that, when reconstituted with drinking water, at the tim...
|
|
WO/2022/181782A1 |
The main purpose of the present invention is to newly provide a technique whereby it becomes possible to shorten the amount of time for anaerobic fermentation by reducing the concentration of oxygen contained in a raw material by a metho...
|
|
WO/2022/177547A1 |
This disclosure provides recombinant placental alkaline phosphatase and highly purified human placental alkaline phosphatase for the treatment of a chemotherapy treated cancer patient to reduce chemotherapy-induced loss of red blood cell...
|
|
WO/2022/177418A1 |
The present invention relates to: an umami-enhancing composition containing tyrosine-amino acid peptide as an active ingredient; umami-enhancing processed food comprising the composition; a method for producing umami-enhanced processed f...
|
|
WO/2022/174606A1 |
An infant formula milk powder rich in structured lipid OPL, and a preparation method therefor. The infant formula milk powder rich in structured lipid OPL is prepared by means of taking raw cow milk as the main raw material, adding a mix...
|
|
WO/2022/171203A1 |
Provided is a Bifidobacterium lactis. The Bifidobacterium lactis is Bifidobacterium lactis BL-11, and the preservation number of the Bifidobacterium lactis BL-11 is CGMCC No. 20847. The provided Bifidobacterium lactis can improve intesti...
|
|
WO/2022/173029A1 |
The purpose of the present invention is to inhibit syneresis of an acidic protein food. The present inventors found that, by using water-soluble pea polysaccharides, syneresis of an acidic protein food can be inhibited and an acidic prot...
|
|
WO/2022/166641A1 |
A new use of a nucleotide, specifically relating to a use of the nucleotide in the preparation of a drug for preventing and treating diseases such as allergic rhinitis or a functional food for relieving symptoms of allergic rhinitis. The...
|
|
WO/2022/166978A1 |
Provided are a genetically engineered probiotic intestinal bacterium, comprising an exogenous expression cassette comprising a nucleotide sequence that encodes acetaldehyde dehydrogenase, wherein the probiotic intestinal bacterium is Esc...
|
|
WO/2022/167533A1 |
The invention relates to a method of making sugar beet cross-linked pectin microgel particles. Food products comprising said microgel particles are also provided, for example confectionery products, beverage products, and meat analogue p...
|
|
WO/2022/167134A1 |
The present invention relates generally to the field of plant-based food. In particular, the present invention relates to improving the vitamin B12 content of plant-based food products. One embodiment of the present invention relates to ...
|
|
WO/2022/167683A1 |
The present invention relates to an improved method of producing beta-lactoglobulin (BLG) compositions by crystallisation of BLG. The invention makes use of at least two different BLG-containing protein feeds which are mixed to prepare a...
|
|
WO/2022/164397A1 |
The innovative and inventive combination of different organic and natural ingredients has enabled the development of a satiating energy formulation which is in the form of a juice and a milky juice, and which considerably enhances perfor...
|
|
WO/2022/163323A1 |
The present invention addresses the problem of providing: a composition for improving joint function, which promotes the proliferation of cartilage cells and inhibits the production of inflammation factors, cartilage matrix degradation f...
|
|
WO/2022/157420A1 |
It is disclosed a lactose free milk powder composition com-prising a citrate preparation, a method for its production, and a method for producing a lactose free low sugar acidified milk product using the lactose free milk powder composit...
|
|
WO/2022/157421A1 |
It is disclosed a method for producing a low sugar acidified milk product, comprising the steps of: providing a milk base having a protein content of about 2.5% to about 8%, a fat con-tent of about 0% to about 10%, a lactose content of a...
|
|
WO/2022/159807A1 |
The present invention relates to a stabilizer composition comprising colloidal microcrystalline cellulose coprocessed with unrefined and unmodified red seaweed flour derived from a red seaweed of the class Rhodophyta.
|
|
WO/2022/159947A1 |
This invention provides a liquid nutritional composition comprising fresh whole milk and chymosin and optionally additional ingredients selected from lactase, lipases or esterases, prebiotics, and probiotics or a combination thereof. In ...
|
|
WO/2022/151790A1 |
A Bifidobacterium longum dietary combination for intervening with chronic nephritis and uremia, and the use thereof. The Bifidobacterium longum dietary combination comprises 100 mL of Bifidobacterium longum BL-G301 probiotic milk and 40 ...
|
|
WO/2022/152615A1 |
The present invention relates to a novel Streptococcus thermophilus strain having improved texturizing properties, compositions comprising said strain as well as fermented products manufactured using said strain.
|
|
WO/2022/148549A1 |
A device for obtaining protein-enriched fractions from human or animal milk comprises a delipidating unit for reducing a lipid content in the human or animal milk to obtain delipidated milk and a filtering unit for increasing a protein c...
|
|
WO/2022/149072A1 |
An edible formulation including: sweetener particles containing at least one of a sweetener carbohydrate and a sweetener polyol, and a milk protein disposed within the sweetener particles, wherein a weight content of the milk protein wit...
|
|
WO/2022/148871A1 |
A neutral dairy dessert product having a specific milk protein, sugar and galacto- oligosaccharides compositions is disclosed. Especially, the neutral dairy dessert product comprises from 1wt.% to 15wt.% of milk proteins, from 0wt.% to 3...
|
|
WO/2022/144447A1 |
The present invention provides a process of producing a lactose concentrate, said process comprising the step of subjecting a partially demineralised aqueous lactose isolate to electrodialysis to produce a biotin-reduced lactose isolate ...
|
|
WO/2022/143781A1 |
A structured emulsion, comprising: 2-6% of an oil phase composition, 7-20% of a water-soluble composition, and 74-92% of water. In terms of fatty acids in the oil phase composition, the content of saturated fatty acids is less than or eq...
|
|
WO/2022/144483A1 |
Disclosed are a Lactobacillus plantarum strain, the probiotic use of same by means of a gastro-resistant capsule, and a bioactive product coated with an antimicrobial whey coating formulation obtained by fermenting whey using said strain...
|
|
WO/2022/136536A1 |
The present invention relates to a novel process for preparing an isolate of cationic whey proteins containing high purity lactoferrin.
|
|
WO/2022/134658A1 |
Provided is a Bifidobacterium breve strain capable of preventing and alleviating psoriasis, and an application thereof, belonging to the technical field of micro-organisms and the technical field of medicines. Provided are new uses of Bi...
|
|
WO/2022/135700A1 |
Disclosed are enzymes, compositions, genetically engineered cells and methods for the fermentative production of 6'-sialyllactose.
|
|
WO/2022/134710A1 |
A strain of Lactobacillus fermentum CCFM1139 and an application thereof are provided. The Lactobacillus fermentum has a preservation number of GDMCC No: 61116, and has the effect of relieving periodontitis. Same can inhibit the formation...
|
|
WO/2022/129525A1 |
The invention relates to a processed dairy-type food product comprising phytic acid salt, the dairy product having a pH between 4.5 and 8, preferably 5 and 8. The dairy-type product can for example be a dairy cheese product, high protein...
|
|
WO/2022/131192A1 |
This composition comprises a lactic acid bacteria belonging to the genus Lactobacillus, and intake of the composition by a subject improves inflammation in the brain tissue of the subject.
|
|
WO/2022/131409A1 |
The present invention provides a single-phase composition derived from a whey protein concentrate and relates to a whey-derived polar lipids-concentrated fraction composition, which is derived from a fraction obtained by treating the whe...
|
|
WO/2022/129518A1 |
Synthetic nutritional compositions tailored for Chinese infants comprising 3'-SL and 6'-SL in concentrations reflecting those found in human milk produced for infants from the same regional location.
|
|
WO/2022/129556A1 |
The present invention relates to composition comprising 2'-FL for use in promoting accelerated butyrate production in the gut thereby preventing and/or treating a health disorder, and/or promoting a health benefit in young children consu...
|
|
WO/2022/129127A1 |
Process for producing a serum protein concentrate (SPC) enriched in immunoglobulins, said process comprising microfiltration (MF) of a feed stream comprising mature bovine skimmed milk diluted with water to a water/milk volume ratio of 0...
|
|
WO/2022/117169A1 |
The invention relates to a crystallization device (101) for crystallizing a precursor, wherein the crystallization device has an inlet (119) for receiving the precursor, a rotary drive (113) and a rotatable receiving unit (103), wherein ...
|
|
WO/2022/117808A1 |
The invention relates to a method for manufacturing a dessert item (1). The method comprises the following consecutive steps: supplying a container (2) with a filling device, the container (2) comprising a bottom (3), a top and a side wa...
|
|
WO/2022/117710A1 |
The present invention concerns a stable aqueous composition comprising at least one human milk oligosaccharide for use in use in promoting postnatal growth in preterm infants as early as 3 weeks after supplementation, wherein the composi...
|
|
WO/2022/117830A1 |
The present invention relates to a nutritional composition comprising fucosylated human milk oligosaccharides for improving sleep maturation in a subject.
|
|
WO/2022/119815A1 |
Disclosed herein are cultured milk product compositions that comprise protein, lipid, and oligosaccharide components at concentrations that mimic and/or are substantially similar to bovine milk. The cultured milk product compositions inc...
|
|
WO/2022/112284A1 |
A bacterial strain which has been modified to reduce the activity and/ or expression of autolysin, wherein said modified strain has reduced sensitivity to bacteriophage, bacterial compositions comprising the bacterial strain and use of t...
|
|
WO/2022/110281A1 |
The present invention pertains to the field of bioengineering, and discloses a Bifidobacterium bifidum i771, a separation and purification method therefor, and an application thereof. The bacterial strain is screened from infant feces, a...
|
|
WO/2022/110725A1 |
Disclosed is the use of Bifidobacterium lactis BL-99 in the preparation of a composition for the improvement of intestinal immunity. The Bifidobacterium lactis has a deposit number of CGMCC No.15650. The composition comprises a food comp...
|
|
WO/2022/115669A1 |
A method of forming a heat-treated liquid nutritional composition having a neutral pH and comprising a water-insoluble plant flavonoid comprises providing an aqueous liquid nutritional composition having a pH of from about 6 to about 7.5...
|
|
WO/2022/110542A1 |
Disclosed is the use of a breast milk oligosaccharide in the preparation of a food product for improving intestinal microenvironment health. Improving intestinal microenvironment health comprises: in the intestinal system, using the brea...
|
|
WO/2022/115168A2 |
Methods for manufacturing a freeze-dried froyo bite snack product are provided. In some implementations, a method includes forming a blended froyo mix comprising frozen yogurt mix, a flavoring agent, and a quantity of probiotics sufficie...
|
|
WO/2022/111782A1 |
The coronavirus disease 2019 (COVID‑19) is a pandemic outbreak caused by infection with the severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2). According to official data from the World Health Organization, by Dec 28th, 2...
|
